2009 Work Groups

PILOT™ Work Group #2:
Latest Developments in Therapy for IPF

Objective

  • Discuss recent evidence for treatments in the management of IPF

Paul W. Noble, MD, FCCP (Lead)
Duke University School of Medicine
Durham, North Carolina

Jeffrey A. Golden, MD
University of California, San Francisco
San Francisco, California

Glenn D. Rosen, MD
Stanford University School of Medicine
Stanford, California